GeneDx Holdings Corp.

US$62.37As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:WGSHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (24.77%)
Div yield —
ROE (40.80%)
Diagnostics & Research
Beta (5Y) 1.99
PE TTM —
TSR TTM (54.44%)
Mkt cap US$1.860B
ROIC (22.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$76
21.15%
(89.95%)
Buy 12|5|9|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.23
1.27
1.39
1.38
29.26%
24.52%
22.17%
22.54%
Revenue$M
89.51
93.75
92.91
94.83
8.86%
8.63%
8.87%
7.37%
Peers (US$1.860B)
Cap (US$)
PE
2.179B
—
1.950B
15.78x
1.712B
—
1.960B
47.34x
Capital
TTM
5Y
10Y
Leveragex
3.433
0.681
0.513
EBIT/Intx
0.937
0.588
0.562
Own earn%
(77.85)
(49.19)
(37.46)
Sh yield%
9.89
34.41
32.55
Owners
Insiders/Inst%
8.62
32.97
Short interest%
5.63
SBC / revenue%
2.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
3–8
$1 testx
0.0
Incr. ROIC%
3